Suchen und Finden

Titel

Autor/Verlag

Inhaltsverzeichnis

Nur eBooks für mein Endgerät anzeigen:

 

Newsletter

Cardiovascular Disease in the Elderly

Cardiovascular Disease in the Elderly

von: Gary Gerstenblith

Humana Press, 2005

ISBN: 9781592599417, 432 Seiten

Format: PDF

Mac OSX,Windows PC Apple iPad, Android Tablet PC's

Preis: 96,25 EUR

  • Clinical Forensic Medicine - A Physician's Guide
    Management of Prader-Willi Syndrome
    Small Bowel Obstruction - CT Features with Plain Film and US correlations
    Pädiatrische Rheumatologie - Mit 335 Abbildungen, davon 201 in Farbe und 131 Tabellen
    Stroke Prevention in Clinical Practice
    Klinische Kinderkardiologie - Diagnostik und Therapie der angeborenen Herzfehler
    Color Atlas of Infective Endocarditis
    Pediatric Inflammatory Bowel Disease
  • Betriebliche Gesundheitsförderung erfolgreich umsetzen - Praxishandbuch für Pflege- und Sozialdienste
    Kinderorthopädie in der Praxis
    The role of physical exercise in disease prevention and quality of life improvement
    Surgical Neuroangiography - Clinical and Interventional Aspects in Children
    Seniorenspielbuch - Reaktivierung Dementer in Pflege und Betreuung. Mit 200 Spielideen
    Brücken zwischen dir und mir - Betreuung zu Hause erleben
    Color Atlas of Strabismus Surgery - Strategies and Techniques
    Dynamic Regression Models for Survival Data
 

Mehr zum Inhalt

Cardiovascular Disease in the Elderly


 

A panel of clinicians, researchers, and leaders in the field review and discuss the latest findings on the pathophysiology, diagnosis, and management of cardiovascular disease in the older patient. The authors explain the physiological changes associated with the normal aging process that may lead to the development of disease, to adverse consequences once disease develops, and which alter the risk-benefit equation for medical and other interventions designed to diagnose, assess, and treat cardiovascular disease. The focus is on particularly common syndromes in the elderly, including cardiac failure with normal ejection fraction, isolated systolic hypertension, and atrial fibrillation. Wherever possible, the authors take an evidence-based approach to recommendations and rely heavily on prospective clinical trials.